AUR three-lens brief
Evidence-based stock research on AUR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Underperforming SPY by 16.6pp over 30 days.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 16.6pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $11.55 — 151% above current (12 analysts).
- Negative free cash flow last quarterly (-$455.12M).
AUR closed at $4.60 (+1.10%) as of 2026-11-12. Market cap: $9.29B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $11.55 — 151% above current (12 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 16.6pp over 30 days.. Last quarter: Revenue $3.00M, net income -$234.00M, free cash flow -$455.12M.
Why three lenses on AUR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AUR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AUR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AUR brief"></iframe>